Cibus Announces Steps to Implement More Streamlined Business Focus on its Nearest Term Revenue Opportunities
Cibus (NASDAQ:CBUS), an agricultural technology company, announced a reduction in force (RIF) as part of implementing its streamlined business strategy. The company will focus on its nearest-term revenue opportunities, particularly in rice weed management traits and biofragrance products.
The restructuring will incur one-time charges of approximately $0.5 million in Q3 2025. Through these initiatives, Cibus aims to reduce its annual net cash usage to approximately $30 million by 2026. The company will prioritize its Trait Machine鈩� gene editing processes for HT1, HT3, and other trait combinations while maintaining customer-funded crop-based sustainable ingredients programs.
Cibus (NASDAQ:CBUS), un'azienda di tecnologia agricola, ha annunciato una riduzione del personale (RIF) come parte dell'implementazione della sua strategia aziendale semplificata. L'azienda si concentrer脿 sulle opportunit脿 di ricavi a breve termine, in particolare sulle caratteristiche per la gestione delle infestanti del riso e sui prodotti biofragranze.
La ristrutturazione comporter脿 oneri una tantum di circa 0,5 milioni di dollari nel terzo trimestre 2025. Attraverso queste iniziative, Cibus mira a ridurre il consumo netto annuo di cassa a circa 30 milioni di dollari entro il 2026. L'azienda dar脿 priorit脿 ai processi di editing genetico Trait Machine鈩� per HT1, HT3 e altre combinazioni di caratteristiche, mantenendo al contempo i programmi sostenibili di ingredienti basati sulle colture finanziati dai clienti.
Cibus (NASDAQ:CBUS), una empresa de tecnolog铆a agr铆cola, anunci贸 una reducci贸n de personal (RIF) como parte de la implementaci贸n de su estrategia empresarial simplificada. La compa帽铆a se enfocar谩 en sus oportunidades de ingresos a corto plazo, particularmente en las caracter铆sticas para el manejo de malezas en arroz y los productos biofragancia.
La reestructuraci贸n generar谩 cargos 煤nicos de aproximadamente 0.5 millones de d贸lares en el tercer trimestre de 2025. A trav茅s de estas iniciativas, Cibus busca reducir su uso neto anual de efectivo a aproximadamente 30 millones de d贸lares para 2026. La empresa priorizar谩 sus procesos de edici贸n gen茅tica Trait Machine鈩� para HT1, HT3 y otras combinaciones de caracter铆sticas, manteniendo al mismo tiempo los programas sostenibles de ingredientes basados en cultivos financiados por clientes.
Cibus (NASDAQ:CBUS)電� 雴嶌梾 旮办垹 須岇偓搿滌劀, 臧勳唽頇旊悳 牍勳雼堨姢 鞝勲灥鞚� 鞁ろ枆頃橂姅 鞚柬櫂鞙茧 鞚鸽牓 臧愳稌(RIF)鞚� 氚滍憸頄堨姷雼堧嫟. 須岇偓電� 氩� 鞛§磮 甏�毽� 韸轨劚瓿� 氚旍澊鞓ろ枼 鞝滍拡瓿� 臧欖潃 雼赴 靾橃澋 旮绊殞鞐� 歆戩頃� 鞓堨爼鞛呺媹雼�.
鞚措矆 甑“臁办爼鞙茧 鞚疙暣 2025雲� 3攵勱赴鞐� 鞎� 50毵� 雼煬鞚� 鞚柬殞靹� 牍勳毄鞚� 氚滌儩頃� 瓴冹瀰雼堧嫟. 鞚措煬頃� 臁办箻毳� 韱淀暣 Cibus電� 2026雲勱箤歆� 鞐瓣皠 靾� 順勱笀 靷毄鞎§潉 鞎� 3觳滊 雼煬搿� 欷勳澊電� 瓴�鞚� 氇╉憸搿� 頃橁碃 鞛堨姷雼堧嫟. 須岇偓電� HT1, HT3 氚� 旮绊儉 韸轨劚 臁绊暕鞚� 鞙勴暅 Trait Machine鈩� 鞙犾爠鞛� 韼胳 頂勲靹胳姢毳� 鞖办劆鞁滍晿氅�, 瓿犼皾 鞛愱笀鞙茧 鞖挫榿霅橂姅 鞛戨 旮半皹 歆�靻� 臧�電ロ暅 靹彪秳 頂勲攴鸽灗霃� 鞙犾頃� 瓿勴殟鞛呺媹雼�.
Cibus (NASDAQ:CBUS), une entreprise de technologie agricole, a annonc茅 une r茅duction des effectifs (RIF) dans le cadre de la mise en 艙uvre de sa strat茅gie commerciale simplifi茅e. L'entreprise se concentrera sur ses opportunit茅s de revenus 脿 court terme, notamment dans les caract茅ristiques de gestion des mauvaises herbes du riz et les produits biofragrances.
La restructuration entra卯nera des charges exceptionnelles d'environ 0,5 million de dollars au troisi猫me trimestre 2025. Gr芒ce 脿 ces initiatives, Cibus vise 脿 r茅duire son utilisation nette annuelle de tr茅sorerie 脿 environ 30 millions de dollars d'ici 2026. L'entreprise donnera la priorit茅 脿 ses processus d'茅dition g茅n茅tique Trait Machine鈩� pour HT1, HT3 et d'autres combinaisons de caract茅ristiques tout en maintenant les programmes durables d'ingr茅dients 脿 base de cultures financ茅s par les clients.
Cibus (NASDAQ:CBUS), ein Unternehmen f眉r Agrartechnologie, gab eine Personalreduzierung (RIF) im Rahmen der Umsetzung seiner gestrafften Gesch盲ftsstrategie bekannt. Das Unternehmen wird sich auf kurzfristige Umsatzchancen konzentrieren, insbesondere auf Reis-Unkrautmanagement-Eigenschaften und Bio-Duftstoffe.
Die Umstrukturierung wird im dritten Quartal 2025 einmalige Kosten von etwa 0,5 Millionen US-Dollar verursachen. Durch diese Ma脽nahmen strebt Cibus an, den j盲hrlichen Netto-Cash-Verbrauch bis 2026 auf etwa 30 Millionen US-Dollar zu senken. Das Unternehmen wird seine Trait Machine鈩�-Geneditierungsprozesse f眉r HT1, HT3 und andere Eigenschaftskombinationen priorisieren und gleichzeitig kundenfinanzierte, nachhaltige Inhaltsstoffprogramme auf Pflanzenbasis beibehalten.
- None.
- One-time restructuring charges of $0.5M in Q3 2025
- Reduction in workforce affecting company operations
- Narrowing of business focus may limit growth opportunities in other areas
Insights
Cibus' staff reduction aims to cut cash burn to $30M by 2026, focusing on rice traits and bio-ingredients while deprioritizing other programs.
Cibus is implementing a significant strategic pivot through a reduction in force that will cost
The company is prioritizing three main areas: (1) weed management traits in rice through its HT1, HT3 and other trait combinations; (2) customer-funded sustainable ingredients programs; and (3) bio-based fermentation fragrance products. Notably, this restructuring appears to be deprioritizing work on traits for canola, winter oilseed rape (WOSR), and soybean, which are now being positioned as partnership opportunities rather than core internal development programs.
This strategic realignment suggests Cibus is responding to capital constraints by focusing on its most promising revenue-generating opportunities while reducing expenditures on longer-term projects. The company's Trait Machine gene editing platform remains central to its business model, but with a narrower application focus. Management's emphasis on seeking external partnerships for its non-core trait portfolio indicates a shift toward a more capital-efficient business model that leverages industry collaborations rather than fully internal development for certain crops.
The restructuring signals both financial discipline and a recognition that the company needs to concentrate resources on areas with the clearest path to commercialization and revenue generation. For an agricultural technology company developing traits for licensing, this more focused approach may enhance the probability of near-term commercial success, though potentially at the expense of longer-term growth across multiple crop platforms.
Previously Announced Strategy Focus Prioritizes Opportunities in Rice and Biofragrance Products and Sustainable Ingredients with Initiatives Expected to Reduce Annual Net Cash Usage to Approximately
Cibus Well Situated to Pursue Partner Funding to Support its Advanced Productivity Trait Portfolio
SAN DIEGO, July 23, 2025 (GLOBE NEWSWIRE) -- Cibus, Inc. (Nasdaq: CBUS) (the "Company"), a leading agricultural technology company that develops plant traits to license to seed companies for royalties, announced a reduction in force (鈥淩IF鈥�) as a pivotal step in implementing its previously announced streamlined business focus, prioritizing its nearest-term and currently funded commercial opportunities. The RIF is expected to result in related one-time charges of approximately
Cibus expects the RIF, along with other initiatives, to reduce its annual net cash usage to approximately
Dr. Peter Beetham, Co-Founder and Interim CEO of Cibus stated, 鈥淭he whole Cibus team has made incredible contributions to advance the burgeoning gene edited trait industry. We are proud of the leadership this team has shown in the development of value-added crop traits. As in many industries, we also see a natural evolution in our markets that drives our commercial focus and development efforts. While we are streamlining to prioritize our efforts on weed management in Rice, sustainable ingredients and biofragrance products, I believe we have significant opportunities to capitalize on our remaining portfolio of developed and advanced traits through industry partnerships in areas such as disease resistance in Canola, WOSR, and Soybean.鈥�
About Cibus
Cibus is a leader in gene edited productivity traits that address critical productivity and sustainability challenges for farmers such as diseases and pests, which the聽United Nations聽estimates cost the global economy approximately聽
Forward Looking Statements
This press release contains "forward-looking statements" within the meaning of applicable securities laws, including The Private Securities Litigation Reform Act of 1995. All statements, other than statements of present or historical fact included herein, including statements regarding Cibus' revenue opportunities, cost-savings initiatives, anticipated cash burn reductions and the timing thereof and anticipated costs associated with the RIF. Forward-looking statements may be identified by words such as "anticipate," "believe," "intend," "expect," "plan," "scheduled," "could," "would" and "will," or the negative of these and similar expressions.
These forward-looking statements are based on the current expectations and assumptions of Cibus' management about future events, which are based on currently available information. Cibus' actual results, level of activity, performance, or achievements could be materially different than those expressed, implied, or anticipated by forward-looking statements due to a variety of factors. These forward-looking statements are subject to numerous risks and uncertainties, many of which are difficult to predict and beyond the control of Cibus. The industry in which Cibus operates is emerging and subject to a high degree of uncertainty and risk due to a variety of factors, including those described in the "Risk Factors" section of Cibus' Annual Report on Form 10-K which was filed with the聽Securities and Exchange Commission聽(the "SEC") on聽March 20, 2025 and other subsequent reports on Forms 10-Q and 8-K as may be filed with the SEC. Should one or more of these risks or uncertainties occur, or should underlying assumptions prove incorrect, actual results and plans could differ materially from those expressed in any forward-looking statements.聽
In addition, the forward-looking statements included in this press release represent Cibus' views as of the date hereof. Cibus specifically disclaims any obligation to update such forward-looking statements in the future, except as required under applicable law. These forward-looking statements should not be relied upon as representing Cibus' views as of any date subsequent to the date hereof.
CIBUS CONTACTS:
INVESTOR RELATIONS
Jeff Sonnek
[email protected]
MEDIA RELATIONS
[email protected]
Colin Sanford
[email protected]
203-918-4347
FAQ
What restructuring changes did Cibus (CBUS) announce in July 2025?
How much will Cibus (CBUS) reduce its annual cash usage by 2026?
What are the main focus areas for Cibus after the restructuring?
What partnership opportunities is Cibus pursuing after the restructuring?
When will Cibus implement the workforce reduction?
